Workflow
American Oncology Network Inc(AONC)
icon
Search documents
American Oncology Network Central Lab Receives Reaccreditation from College of American Pathologists
Globenewswire· 2025-07-24 12:00
Core Points - American Oncology Network (AON) has received reaccreditation from the College of American Pathologists (CAP) for its Central Laboratory in Fort Myers, Florida, following a recent on-site inspection [1][3] - CAP accreditation ensures laboratories operate at high levels of accuracy and reliability, contributing to improved patient outcomes and reduced clinical risk [2] - The reaccreditation reflects AON's commitment to quality standards in laboratory medicine, which plays a critical role in modern cancer care [3][4] Company Overview - AON is an alliance of physicians and healthcare leaders focused on the long-term success of community oncology, founded in 2018, representing over 290 providers across 21 states [7] - The organization promotes innovative healthcare solutions through a physician-led model, emphasizing value-based care to improve patient outcomes while reducing costs [7] - AON is dedicated to health equity, addressing disparities in cancer care, and ensuring all patients have access to necessary care for optimal health outcomes [7]
Auerbach Hematology and Oncology Joins American Oncology Network, Becomes The Center for Cancer and Blood Disorders – Baltimore
Globenewswire· 2025-07-15 12:00
Core Viewpoint - Auerbach Hematology and Oncology Associates PC has joined the American Oncology Network (AON), rebranding as The Center for Cancer and Blood Disorders (CCBD)—Baltimore, to enhance patient services and expand clinical trial offerings [1][11]. Company Overview - Auerbach Hematology and Oncology Associates PC has been providing cancer care in Baltimore for 24 years and is now part of AON, which represents over 290 providers across 21 states [10][11]. - The practice specializes in the diagnosis and treatment of blood disorders and cancer, offering services such as chemotherapy, targeted therapy, immunotherapy, and clinical trials [12]. Leadership and Expertise - Dr. Michael Auerbach, Dr. Huzefa Bahrain, and Stephanie Horrocks are key figures in the practice, with extensive backgrounds in hematology and oncology [3][4][5]. - Dr. Auerbach is recognized for his expertise in iron deficiency anemia and serves as a Clinical Professor at Georgetown University [3]. - Dr. Bahrain is a key opinion leader in intravenous iron treatment and has multiple publications in the field [4]. Partnership Benefits - The partnership with AON allows CCBD to provide innovative, high-quality, and personalized cancer care while maintaining a patient-centered approach [6][9]. - The collaboration aims to enhance service delivery and improve patient outcomes through expanded offerings and resources [6][9]. Community Impact - CCBD serves patients in Baltimore, Bethesda, and Germantown, Maryland, focusing on reducing travel burdens for patients and their families [8]. - The practice features private exam rooms and on-site infusion suites to ensure patient comfort and privacy during treatment [8].
Florida Oncology and Hematology Expands Fort Myers Clinic, Adds PET Services
Globenewswire· 2025-07-15 12:00
Company Overview - Florida Oncology and Hematology has expanded its Fort Myers clinic to include radiology services, enhancing cancer care for the Lee County community [1][3] - The practice operates five clinics in the region, providing personalized care plans tailored to individual patient needs [3][8] - Florida Oncology and Hematology is a partner of American Oncology Network (AON), which is one of the fastest-growing community oncology networks in the United States [4][7] Services Offered - The expanded clinic now offers PET services, 12 exam rooms for consultations, nearly 30 infusion chairs, and an on-site lab [2] - The addition of PET services allows for diagnostic PET and CT imaging, as well as innovative Radioligand Therapy for treating various cancers [5] - AON provides access to expanded services such as an in-house specialty pharmacy for home delivery of select medications [4][7] Commitment to Care - The medical director emphasizes the importance of delivering compassionate, high-quality care in a comprehensive and comfortable setting [3] - AON is committed to promoting health equity and addressing disparities in cancer care, ensuring all patients have access to necessary treatments [7] - The practice focuses on providing high-quality, affordable care in a supportive and accessible environment [3][8]
Hope Cancer Care of Nevada and American Oncology Network Open New Henderson Clinic
Globenewswire· 2025-07-08 12:00
Core Insights - Hope Cancer Care of Nevada has opened its third location in Henderson, expanding access to oncology and hematology services for patients in Clark County [1][3] - The new clinic features private exam rooms, an infusion room, and a specialty pharmacy for oral oncolytics, enhancing patient care [2][3] - The practice emphasizes a patient-first approach, aiming to provide high-quality, compassionate care across all its locations [3][4] Company Overview - Hope Cancer Care of Nevada specializes in the diagnosis and treatment of cancer and blood disorders, serving the Las Vegas and Pahrump areas for 15 years [7] - The practice is part of the American Oncology Network (AON), which represents over 290 providers across 21 states, focusing on community oncology and innovative healthcare solutions [6][7] - AON is committed to promoting health equity and improving patient outcomes while reducing costs through a physician-led model [6]
Florida Oncology and Hematology Relocates Naples Health Parkway Clinic to Larger Location in Lintree Medical Plaza; Adds PET Services
Globenewswire· 2025-07-01 12:00
Core Insights - Florida Oncology and Hematology has relocated its Health Parkway clinic in Naples to a larger suite to enhance cancer care for the Collier County community [1][4] - The new clinic offers expanded services including PET services, an infusion room, private exam rooms, in-house lab and pathology services, and an onsite specialty pharmacy [3][4] - The practice is part of the American Oncology Network, which supports community-based oncology practices and provides additional patient care services [6][9] Company Overview - Florida Oncology and Hematology specializes in the diagnosis and treatment of cancer and blood disorders, serving patients in Cape Coral, Clearwater, Fort Myers, and Naples [10] - The practice is committed to delivering personalized care plans and high-quality treatment in a supportive environment [5][10] - American Oncology Network, founded in 2018, represents over 290 providers across 21 states and focuses on value-based care to improve patient outcomes [9]
Florida Oncology and Hematology Moves Naples-Goodlette Clinic to Larger Location
Globenewswire· 2025-06-11 12:00
Core Insights - Florida Oncology and Hematology has relocated its Goodlette clinic in Naples to a larger facility to enhance cancer care services for the local community [1][3] - The new clinic features additional private exam rooms, an infusion room, in-house lab and pathology services, and an onsite specialty pharmacy [2][5] - The practice is part of the American Oncology Network, which supports community-based oncology practices and provides additional patient care services [4][7] Company Overview - Florida Oncology and Hematology specializes in the diagnosis and treatment of cancer and blood disorders, serving patients in Cape Coral, Clearwater, Fort Myers, and Naples [8] - The practice emphasizes personalized care and treatment plans tailored to individual patient needs, ensuring affordable and high-quality services [3][8] - American Oncology Network, founded in 2018, is a rapidly expanding network with over 290 providers across 21 states, focusing on value-based care and health equity [6][7]
American Oncology Network Announces Research Studies Presented at ASCO 2025 Annual Meeting
Globenewswire· 2025-06-03 12:00
Core Insights - American Oncology Network (AON) showcased multiple research studies at the ASCO 2025 Annual Meeting, highlighting its commitment to advancing cancer care through evidence-based practices [1][6][8] - AON's participation reflects the organization's focus on innovation, collaboration, and improving patient outcomes in oncology [6][8] Research Highlights - AON physicians co-authored studies on various topics, including the safety and efficacy of ABBV-706 in neuroendocrine neoplasms, racial representation in clinical trials, and real-world outcomes of HER2 directed therapy in early-stage breast cancer [4][5] - Specific studies presented include: - "Bria-IMT + checkpoint inhibitor" in metastatic breast cancer [4] - "Impact of HLA matching on clinical outcomes" in advanced breast cancer [4] - "Real-world data on bispecific antibodies administration" in community oncology settings [5] - AON practices currently offer access to over 150 clinical trials, providing cutting-edge treatment options within local communities [7] Organizational Overview - AON is an alliance of over 290 providers across 21 states, founded in 2018, focusing on community oncology and innovative healthcare solutions [8] - The organization emphasizes value-based care, aiming to improve patient outcomes while reducing costs and expanding access to quality care [8] - AON is committed to promoting health equity and addressing disparities in cancer care [8]
American Oncology Network Expands Access to Advanced Radioligand Therapies Across U.S. Network
Globenewswire· 2025-05-21 12:00
Core Insights - American Oncology Network (AON) is expanding access to radioligand therapies (RLT) for prostate and neuroendocrine cancers, reflecting a commitment to innovative cancer care [1][5] - Over 300 treatments have been administered to nearly 70 patients across five AON partner practices, indicating strong demand and success for these therapies [1][5] Company Overview - AON is a rapidly growing community oncology network founded in 2018, representing over 290 providers across 21 states [6] - The organization focuses on value-based care, improving patient outcomes while reducing costs and expanding access to quality care [6] - AON aims to promote health equity by addressing disparities in cancer care and ensuring all patients have access to necessary treatments [6] Radioligand Therapies - AON now offers three FDA-approved radiopharmaceuticals: Pluvicto™, Xofigo, and Lutathera, targeting specific cancer types [2][3] - Radioligand therapy involves attaching a radioactive isotope to a targeting molecule, allowing for precise radiation delivery to cancer cells while minimizing damage to healthy tissue [2][3] Future Growth - AON anticipates continued growth in the utilization of radioligand therapies as more sites obtain the necessary infrastructure and regulatory approvals [5]
American Oncology Network Appoints Joe Verschleiser as Chief Growth and Performance Officer
Globenewswire· 2025-05-15 12:00
Company Overview - American Oncology Network (AON) is one of the fastest-growing community oncology networks in the United States, founded in 2018, representing over 290 providers across 21 states [6][7] - AON focuses on innovative healthcare solutions through a physician-led model, promoting value-based care that improves patient outcomes while reducing costs [7] Leadership Appointment - Joe Verschleiser has been appointed as the chief growth and performance officer of AON, bringing over a decade of experience in healthcare, including roles in operations, financial strategy, and mergers and acquisitions [2][3] - His previous role was president of the West Division at Unified Women's Healthcare, where he managed strategy and operations for over 200 physicians [3] Strategic Focus - In his new role, Verschleiser will lead growth strategy and performance optimization for AON partner practices, focusing on expansion and new business line opportunities [2] - AON aims to strengthen its national presence and support the long-term success of its partner practices through strategic initiatives [2][4] Commitment to Quality Care - AON is dedicated to expanding access to high-quality, affordable cancer care and addressing disparities in cancer care to promote health equity [4][7] - The organization provides comprehensive support and integrated services to enable physicians to focus on delivering the highest standard of care [7]
American Oncology Network Value-Based Care Director Anne Marie Rainey Appointed to ACCC Board of Trustees
Globenewswire· 2025-04-08 12:00
Core Insights - American Oncology Network (AON) announced the appointment of Anne Marie Rainey as a member of the Association of Cancer Care Centers' Board of Trustees, highlighting AON's commitment to leadership in oncology care [1][4]. Company Overview - AON is a rapidly growing community oncology network founded in 2018, representing over 290 providers across 21 states, focusing on innovative healthcare solutions and value-based care [5]. - The organization aims to improve patient outcomes while reducing costs and expanding access to quality care through a physician-led model [5][6]. Leadership and Initiatives - Anne Marie Rainey, as the director of value-based care at AON, manages quality initiatives and has a background in government quality reporting [3]. - Rainey expressed her commitment to advancing oncology education and advocacy for cancer patients through her role on the ACCC Board [4]. Association of Cancer Care Centers (ACCC) - ACCC is an education and advocacy organization for the cancer care community, consisting of over 45,000 professionals from 1,700 provider organizations [7]. - The organization adapts its resources to meet the evolving needs of oncology care teams, reflecting advancements in cancer treatment and care delivery [7].